Literature DB >> 23830788

Pediatric hepatobiliary magnetic resonance imaging.

Vy Thao Tran1, Shreyas Vasanawala.   

Abstract

Magnetic resonance (MR) imaging is an effective and noninvasive modality for evaluating hepatobiliary pathologic conditions. This article provides an up-to-date review of anatomy, indications, and imaging goals and protocols, including patient preparation, pulse sequences, and contrast agents used in pediatric MR hepatobiliary imaging. This article also highlights some of the common MR features of pediatric liver pathologic conditions, including tumors, congenital biliary ductal plate malformations, trauma, fibrosis, and infection.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatobiliary; Liver; Magnetic resonance imaging; Pediatric patients; Protocol; Sequences

Mesh:

Year:  2013        PMID: 23830788     DOI: 10.1016/j.rcl.2013.03.005

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  4 in total

Review 1.  Gadolinium-based contrast agents in pediatric magnetic resonance imaging.

Authors:  Eric M Gale; Peter Caravan; Anil G Rao; Robert J McDonald; Matthew Winfeld; Robert J Fleck; Michael S Gee
Journal:  Pediatr Radiol       Date:  2017-04-13

Review 2.  Advanced imaging techniques in pediatric body MRI.

Authors:  Jesse Courtier; Anil G Rao; Sudha A Anupindi
Journal:  Pediatr Radiol       Date:  2017-04-13

Review 3.  Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know.

Authors:  Rama S Ayyala; Sudha A Anupindi; Michael S Gee; Andrew T Trout; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2019-07-26

4.  The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study.

Authors:  Sarah Poetter-Lang; Katharina Staufer; Pascal Baltzer; Dietmar Tamandl; Dina Muin; Nina Bastati; Emina Halilbasic; Jacqueline C Hodge; Michael Trauner; Lili Kazemi-Shirazi; Ahmed Ba-Ssalamah
Journal:  Eur Radiol       Date:  2018-07-27       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.